scispace - formally typeset
M

Michael J. Cooke

Researcher at Durham University

Publications -  43
Citations -  2397

Michael J. Cooke is an academic researcher from Durham University. The author has contributed to research in topics: Transplantation & Progenitor cell. The author has an hindex of 22, co-authored 42 publications receiving 2135 citations. Previous affiliations of Michael J. Cooke include University of Toronto & Newcastle University.

Papers
More filters
Journal ArticleDOI

A hydrogel-based stem cell delivery system to treat retinal degenerative diseases

TL;DR: In vivo transplantation studies in mice showed that RSPCs delivered in HAMC were more evenly distributed in the sub-retinal space than those delivered in traditional saline solutions, suggesting that HAMC is a promising vehicle for cellular delivery to the degenerating retina overcoming previously reported barriers to tissue integration in the retina.
Journal ArticleDOI

Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos

TL;DR: Analysis of arrested embryos demonstrated that these embryos express pluripotency marker genes such OCT4, NANOG, and REX1, which demonstrate that arrested embryos are additional valuable resources to surplus and donated developing embryos and should be used to study early human development or derive pluripotent hESC.
Journal ArticleDOI

A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A

TL;DR: It is shown that NANOG, a master transcription factor, regulates S-phase entry in human embryonic stem cells (hESCs) via transcriptional regulation of cell cycle regulatory components through C-terminal region binds to the regulatory regions of CDK6 and CDC25A genes under normal physiological conditions.
Journal ArticleDOI

A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation

TL;DR: The proposed injectable and bioresorbable hydrogel blend of hyaluronan and methylcellulose (HAMC) improves cell survival and integration of retinal stem cell-derived rods in the retina and improves cell transplantation efficacy in two CNS models, suggesting broad applicability.
Journal ArticleDOI

Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury.

TL;DR: Erythropoietin delivered from HAMC at 4 and 11 days post-stroke resulted in attenuated inflammatory response, reduced stroke cavity size, increased number of both neurons in the peri-infarct region and migratory neuroblasts in the subventricular zone, and decreased apoptosis in both the subventionricular zone and the injured cortex.